Delivery Order SPE2DB24D8002-SPE2DB25FJMQW

Award Date 11/4/24
Potential Completion Date 11/5/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,188.84 and a period of performance through January 24, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $5,944.20 and a period of performance through June 30, 2025. Dakota Drug, Inc. is a critical vendor for the DLA, holding a significant single-award Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The fixed-price contract has a ceiling value of $6,350.45 and a period of performance through March 10, 2025. Dakota Drug, Inc. is an established federal contractor, holding a large Indefinite Delivery Contract (IDC) with the DLA worth up to $999,999,999.00 to provide a wide range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $1,035.87, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through February 6, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,589.88, is for the delivery of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. This contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC is part of the DLA Troop Support Medical's ECAT...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of Mounjaro 10 mg/0.5 ml pens, a pharmaceutical product. The contract has a firm fixed price of $2,178.74 and a completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Dakota Drug, Inc. holds with the DLA, valued at $999,999,999.00,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,500.92 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of MOUNJARO 5 MG/0.5 ML PEN 0.5ML medical supplies. This award is part of Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, under the DLA Troop Support Medical's ECAT Generation V Program. The contract has an ultimate completion date of March 11,...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $2,377.68 and a performance period through April 7, 2025. It is a Firm Fixed Price contract and is not set-aside. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The award, valued at $2,006.80, was made to Dakota Drug, Inc., a self-certified small disadvantaged business, on February 21, 2025, with a completion date of February 24, 2025. The contract is a Firm Fixed Price Delivery Order, and is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,188.84. The contract has an ultimate completion date of May 20, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJMQW
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed-price, with a ceiling value of $2,468.66, and an ultimate completion date of November 5, 2024. This contract is not associated with a set-aside program. Dakota Drug, Inc. is the prime contractor, and there are no major subcontractors mentioned. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations.

Generated 5/20/25, 2:05 PM